Athena opens northeast India’s largest integrated psychiatric hospital in Guwahati

Athena Behavioral Health opens Northeast India's largest private psychiatric hospital in Guwahati. This marks their fifth hospital nationwide. The facility offers integrated treatment for mental health and substance use disorders. It aims to address the region's growing needs and shortage of structured care. The launch signifies a crucial step in making quality mental healthcare accessible in underserved areas.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/wKiVf3e
via IFTTT

Read More

Dr Reddy’s launches generic Semaglutide injection, popular weight-loss drug, in Canada

Dr Reddy's Laboratories has launched its generic Semaglutide injection in Canada. This marks a significant step for the company in providing treatment for type 2 diabetes. Canada is the first G7 nation to approve this medication. The launch follows a recent introduction in India. Dr Reddy's aims to expand access to these therapies globally.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/WrVdyDF
via IFTTT

Read More

Why is healthcare AI stuck in pilot mode? UiPath has a straightforward answer

The gap between a successful AI pilot and a fully transformed healthcare operation is often wider than many organisations expect. UiPath bridges this gap by shifting the focus from simple automation to end-to-end orchestration

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/uZbrVIa
via IFTTT

Read More

Roche brings 7-minute lung cancer shot to India

Roche Pharma India introduces a new injectable immunotherapy for lung cancer. This treatment takes only seven minutes, a significant reduction from hours-long infusions. It offers a less burdensome option for thousands of patients. The medicine, subcutaneous Tecentriq, is now approved for non-small cell lung cancer. This innovation aims to ease the strain on overcrowded cancer centers across India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/E0hqXGM
via IFTTT

Read More

Drug regulator drafts guidelines on high-risk solvents after tainted syrup deaths in kids

India's drug regulator is creating new rules for dangerous solvents in children's medicines. This follows tragic deaths linked to contaminated cough syrups. Experts found these solvents can contain toxic impurities. The regulator is consulting with companies to assess current practices and explore safer alternatives. This action is vital after several children died from Indian-made cough syrups.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/OltYzga
via IFTTT

Read More

Zydus Lifesciences close to buying US oncology drug maker for $100 to 150 million: Sources

Indian drug maker Zydus Lifesciences is close to acquiring a US company. The deal is expected to be between $100 to $150 million. This acquisition will help Zydus build its own distribution network for anti-cancer drugs in the US. The target company also has its own pipeline of biologic drugs. A deal is anticipated soon.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2KAICpO
via IFTTT

Read More

Alzheimer's a key part of Eli Lilly's India specialty medicine push, says company's country head Winselow Tucker

Eli Lilly has introduced Lormalzi in India, a pioneering treatment for Alzheimer's that specifically targets amyloid plaques, a significant contributor to the condition. Unlike previous therapies that merely alleviate symptoms, this innovative medication aims to modify the disease itself.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/T78HK0t
via IFTTT

Read More